{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:22:13Z","timestamp":1767986533483,"version":"3.49.0"},"publisher-location":"Cham","reference-count":22,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030273774","type":"print"},{"value":"9783030273781","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-27378-1_29","type":"book-chapter","created":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T18:02:49Z","timestamp":1577556169000},"page":"175-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Increased Protein Citrullination as a\u00a0Trigger for Resident Immune System Activation, Intraretinal Inflammation, and Promotion of Anti-retinal Autoimmunity: Intersecting Paths in Retinal Degenerations of Potential Therapeutic Relevance"],"prefix":"10.1007","author":[{"given":"Alessandro","family":"Iannaccone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko Z.","family":"Radic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,29]]},"reference":[{"key":"29_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12348-011-0028-8","volume":"1","author":"G Adamus","year":"2011","unstructured":"Adamus G, Brown L, Schiffman J et\u00a0al (2011) Diversity in autoimmunity against retinal, neuronal, and axonal antigens in acquired neuro-retinopathy. J Ophthalmic Inflamm Infect 1:111\u2013121","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"29_CR2","first-page":"2323","volume":"18","author":"G Adamus","year":"2012","unstructured":"Adamus G, Wang S, Kyger M et al (2012) Systemic immunotherapy delays photoreceptor cell loss and prevents vascular pathology in Royal College of Surgeons rats. Mol Vis 18:2323\u20132337","journal-title":"Mol Vis"},{"key":"29_CR3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/iub.184","volume":"61","author":"SK Bhattacharya","year":"2009","unstructured":"Bhattacharya SK (2009) Retinal deimination in aging and disease. IUBMB Life 61:504\u2013509","journal-title":"IUBMB Life"},{"key":"29_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1474-9726.2008.00376.x","volume":"7","author":"SK Bhattacharya","year":"2008","unstructured":"Bhattacharya SK, Sinicrope B, Rayborn ME et al (2008) Age-related reduction in retinal deimination levels in the F344BN rat. Aging Cell 7:441\u2013444","journal-title":"Aging Cell"},{"key":"29_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.exer.2013.03.017","volume":"111","author":"VL Bonilha","year":"2013","unstructured":"Bonilha VL, Shadrach KG, Rayborn ME et al (2013) Retinal deimination and PAD2 levels in retinas from donors with age-related macular degeneration (AMD). Exp Eye Res 111:71\u201378","journal-title":"Exp Eye Res"},{"key":"29_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10633-012-9327-0","volume":"125","author":"G Carboni","year":"2012","unstructured":"Carboni G, Forma G, Bond AD et al (2012) Bilateral paraneoplastic optic neuropathy and unilateral retinal compromise in association with prostate cancer: a differential diagnostic challenge in a patient with unexplained visual loss. Doc Ophthalmol 125:63","journal-title":"Doc Ophthalmol"},{"key":"29_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/humc.2013.037","volume":"24","author":"TJ Conlon","year":"2013","unstructured":"Conlon TJ, Deng WT, Erger K et al (2013) Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa. Hum Gene Ther Clin Dev 24:23\u201328","journal-title":"Hum Gene Ther Clin Dev"},{"key":"29_CR8","first-page":"E-Abstract 169","volume":"56","author":"RS Epstein","year":"2015","unstructured":"Epstein RS, New DD, Hollingsworth TJ et al (2015) Defective mer-tyrosine kinase (mer-TK) function is associated with anti-arrestin and anti- interphotoreceptor retinoid-binding protein (IRBP) autoantibodies (AAbs) in Mer, Axl, Tyro3\u2212\/\u2212 (TAM) mice and in autosomal recessive retinitis pigmentosa (arRP) patients with a null MERTK mutation. Invest Ophthalmol Vis Sci 56:E-Abstract 169","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"29_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00439-016-1637-y","volume":"135","author":"NG Ghazi","year":"2016","unstructured":"Ghazi NG, Abboud EB, Nowilaty SR et al (2016) Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial. Hum Genet 135:327\u2013343","journal-title":"Hum Genet"},{"key":"29_CR10","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1136\/bjo.69.10.758","volume":"69","author":"JR Heckenlively","year":"1985","unstructured":"Heckenlively JR, Solish AM, Chant SM et al (1985) Autoimmunity in hereditary retinal degenerations. II. Clinical studies: antiretinal antibodies and fluorescein angiogram findings. Br J Ophthalmol 69:758\u2013764","journal-title":"Br J Ophthalmol"},{"key":"29_CR11","first-page":"179","volume":"94","author":"JR Heckenlively","year":"1996","unstructured":"Heckenlively JR, Aptsiauri N, Nusinowitz S et al (1996) Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations. Trans Am Ophthalmol Soc 94:179\u2013200","journal-title":"Trans Am Ophthalmol Soc"},{"key":"29_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0002-9394(98)00446-2","volume":"127","author":"JR Heckenlively","year":"1999","unstructured":"Heckenlively JR, Jordan BL, Aptsiauri N (1999) Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 127:565\u2013573","journal-title":"Am J Ophthalmol"},{"key":"29_CR13","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1167\/iovs.18-24118","volume":"59","author":"TJ Hollingsworth","year":"2018","unstructured":"Hollingsworth TJ, Radic MZ, Beranova-Giorgianni S et al (2018) Murine retinal citrullination declines with age and is mainly dependent on peptidyl arginine deiminase 4 (PAD4). Invest Ophthalmol Vis Sci 59:3808\u20133815","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"29_CR14","unstructured":"Iannaccone A, Vingolo EM, Tanzilli P et al (1994) Long-term results of a pilot study on thymopentin in the treatment of retintitis pigmentosa: pathophysiological considerations [Italian]. In: The IV National Congress of the Italian Association for Ocular Pharmacology (AISFO). MediConsult, Catania"},{"key":"29_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145323","volume":"10","author":"A Iannaccone","year":"2015","unstructured":"Iannaccone A, Giorgianni F, New DD et al (2015) Circulating autoantibodies in age-related macular degeneration recognize human macular tissue antigens implicated in autophagy, immunomodulation, and protection from oxidative stress and apoptosis. PLoS One 10:e0145323","journal-title":"PLoS One"},{"key":"29_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.exer.2016.12.006","volume":"155","author":"A Iannaccone","year":"2017","unstructured":"Iannaccone A, Hollingsworth TJ, Koirala D et al (2017) Retinal pigment epithelium and microglia express the CD5 antigen-like protein, a novel autoantigen in age-related macular degeneration. Exp Eye Res 155:64\u201374","journal-title":"Exp Eye Res"},{"key":"29_CR17","first-page":"616","volume":"12","author":"JE Jones","year":"2009","unstructured":"Jones JE, Causey CP, Knuckley B et al (2009) Protein arginine deiminase 4 (PAD4): current understanding and future therapeutic potential. Curr Opin Drug Discov Devel 12:616\u2013627","journal-title":"Curr Opin Drug Discov Devel"},{"key":"29_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jneuroim.2012.10.007","volume":"254","author":"M Kyger","year":"2013","unstructured":"Kyger M, Worley A, Adamus G (2013) Autoimmune responses against photoreceptor antigens during retinal degeneration and their role in macrophage recruitment into retinas of RCS rats. J Neuroimmunol 254:91\u2013100","journal-title":"J Neuroimmunol"},{"key":"29_CR19","first-page":"E-Abstract 3986","volume":"56","author":"DD New","year":"2015","unstructured":"New DD, Hollingsworth TJ, Giorgianni F et al (2015) The Cu\/Zn+ superoxide dismutase knockout mouse (Sod1\u2212\/\u2212), a model of age-related macular degeneration (AMD), exhibits anti-retinal autoantibodies (AAbs) and marked signs of intraretinal inflammation prior to onset of an AMD-like phenotype. Invest Ophthalmol Vis Sci 56:E-Abstract 3986","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"29_CR20","first-page":"E-Abstract 975","volume":"50","author":"SS Radhakrishnan","year":"2009","unstructured":"Radhakrishnan SS, Laing AE, Adamus G et al (2009) Clinical characteristics of patients with auto-immune retinopathies (AIR) and neuropathies (AIN): differential diagnosis with retinitis pigmentosa (RP). Invest Ophthalmol Vis Sci 50:E-Abstract 975","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"29_CR21","unstructured":"RetNet\u00a0\u2013 Retinal Information Network. \nhttp:\/\/www.sph.uth.tmc.edu\/Retnet\/"},{"key":"29_CR22","first-page":"235","volume":"6","author":"E Rispoli","year":"1991","unstructured":"Rispoli E, Vingolo EM, Iannaccone A (1991) Thymopentin in retinitis pigmentosa. Evaluation of its possible therapeutical effects after 18 months of treatment, preliminary results. New Trends Ophthalmol 6:235\u2013241","journal-title":"New Trends Ophthalmol"}],"container-title":["Advances in Experimental Medicine and Biology","Retinal Degenerative Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-27378-1_29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T09:09:23Z","timestamp":1586423363000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-27378-1_29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030273774","9783030273781"],"references-count":22,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-27378-1_29","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"29 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}